References
- Berk S, Dogan OT, Kilickap S, et al. Clinical characteristics, treatment and survival outcomes in malignant mesothelioma: eighteen years’ experience in Turkey. Asian Pac J Cancer Prev 2013;13:5735-9
- Panou V, Vyberg M, Weinreich UM, et al. The established and future biomarkers of malignant pleural mesothelioma. Canc Treat Rev 2015;41:486-95
- Borasio P, Berruti A, Billé A, et al. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients. Eur J Cardiothorac Surg 2008;33:307-13
- Remon J, Reguart N, Corral J, Lianes P. Malignant pleural mesothelioma: new hope in the horizon with novel therapeutic strategies. Canc Treat Rev 2015;41:27-34
- Levy A, Assouline A, Rivera S, et al. Role of conservative (palliative) care-only in the management of advanced malignant pleural mesothelioma. Anticancer Res 2012;32:4025-8
- Mutlu H, Buyukcelik A, Karaca H, et al. Second line chemotherapy versus best supportive care in patient with malignant pleural mesothelioma: a retrospective study. Asian Pac J Cancer Prev 2013;14:3887-9
- Gunatilake S, Brims FJ, Fogg C, et al. A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial. Trials 2014;15:367
- Abakay A, Tantikulu AC, Kaplan MA, et al. Clinical characteristics and treatment outcomes in 132 patients with malignant mesothelioma. Lung India 2011;28:267-71
- Skammeritz E, Omland LH, Johansen JP, Omland O. Asbestos exposure and survival in malignant mesotheliom: a description of 122 consecutive cases at an occupational clinic. Int J Occup Environ Med 2011;2:224-36
- INAIL, registro nazionale dei mesoteliomi, IV rapporto
- Bruera E, Kuehn N, Miller MJ, et al. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 1991;7:6-9
- Ibrahim N, Abou-Elela E, Darwish D. Survival of mesothelioma in a palliative medical care unit in Egypt. Asian Pac J Cancer Prev 2013;14:739-42
- Mercadante S, Casuccio A, Fulfaro F. The course of symptom frequency and intensity in advanced cancer patients followed at home. J Pain Symptom Manage 2000;20:104-12
- MacLeod N, Chalmers A, O’Rourke N, et al. Is radiotherapy useful for treating pain in mesothelioma? A phase II trial. J Thor Oncol 2015;10:944-50
- Mercadante S, Fulfaro F, Casuccio A. The impact of home palliative care on symptoms in advanced cancer patients. Support Care Canc 2000;8:307-10
- France BD, Lewis RA, Sharma ML, Poolman M. Cordotomy in mesothelioma-related pain: a systematic review. BMJ Support Palliat Care 2014;4:19-29
- Dogan M, Utkan G, Hocazade C, et al. The clinicopathological characteristics with long-term outcomes in malignant mesothelioma. Med Oncol 2014;31:232
- Nagamatsu Y, Nakayama Y, Clayson H, et al. Caring for patients with malignant pleural mesothelioma in Japan: evaluation of a palliative care educational program. Asian Pac J Cancer Prev 2014;15:9165-70